2.20
price up icon0.92%   0.02
after-market After Hours: 2.19 -0.01 -0.45%
loading

Aytu Biopharma Inc Stock (AYTU) Forecast

The Aytu Biopharma Inc (AYTU) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $50.27, representing a +2,185% increase from the current price of $2.20. The highest analyst price target is $42.27, and the lowest is $58.27.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AYTU Price Target
Average 114.21 (+5,091% Upside)
loading

Is Aytu Biopharma Inc (AYTU) A Buy Now?

Oscillators
Name Value Action
RSI(14) 39.45 Neutral
STOCH(9,6) 11.98 Buy
STOCHRSI(14) 3.265 Buy
MACD(12,26) -0.0362 Sell
ADX(14) 19.01 Neutral
William %R -96.26 Buy
CCI(14) -75.78 Neutral
Buy: 3 Sell: 1 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
2.2466
Sell
2.2509
Sell
MA20
2.3886
Sell
2.3041
Sell
MA50
2.2702
Sell
2.2127
Sell
MA100
1.8387
Buy
2.0166
Buy
MA200
1.6817
Buy
1.9947
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, AYTU could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on AYTU, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 39.45 indicates that AYTU is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 11.98 indicates that AYTU is oversold. This indicates that AYTU price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.265 indicates that AYTU is oversold. This suggests that AYTU price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 19.01 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -75.78 indicates that AYTU is still oversold but not to an extreme extent.

Long-term AYTU price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Aytu Biopharma Inc financial reports and earnings history, Aytu Biopharma Inc (AYTU) stock could reach $506.34 by 2030, $295.56 by 2040 and $960.85 by 2050. See the projected annual prices until 2050 of the Aytu Biopharma Inc stock below:

  • Aytu Biopharma Inc (AYTU) is expected to reach an average price of $86.34 in 2035, with a high prediction of $97.93 and a low estimate of $86.60. This indicates an $3,825% rise from the last recorded price of $2.20.
  • Aytu Biopharma Inc (AYTU) stock is projected to chart a bullish course in 2040, with an average price target of $282.26, representing an $12,730% surge from its current level. The forecast ranges from a conservative $282.41 to a sky-high $295.56.
  • Our analysts predict Aytu Biopharma Inc (AYTU) to jump 25,895% by 2045, soaring from $572.03 to an average price of $571.88, potentially reaching $588.54. While $572.03 is the low estimate, the potential upside is significant.
  • Aytu Biopharma Inc (AYTU) stock is expected to climb by 2050, reaching an average of $940.79, a $42,663% jump from its current level. However, a wide range of estimates exists, with high and low targets of $960.85 and $942.79, respectively, highlighting the market's uncertainty.

Aytu Biopharma Inc Stock (AYTU) Year by Year Forecast

Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2025

Aytu Biopharma Inc Stock (AYTU) is expected to reach an average price of $143.01 in 2025, with a high prediction of $235.37 and a low estimate of $50.66. This indicates an +6,401% rise from the last recorded price of $2.20.
Month Average Low High Change from today's price
September, 2025 $56.27 $58.27 $42.27 +2,458%
October, 2025 $128.66 $75.31 $99.34 +5,748%
November, 2025 $80.92 $92.40 $89.37 +3,578%
December, 2025 $121.44 $83.44 $107.50 +5,420%

Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2026

The predicted value for Aytu Biopharma Inc (AYTU) in 2026 is set at an average of $141.54. Estimates vary from a peak of $173.93 to a trough of $109.14, indicating an +6,333% surge from the present price of $2.20.
Month Average Low High Change from today's price
January, 2026 $121.61 $122.53 $116.87 +5,428%
February, 2026 $177.43 $128.88 $164.43 +7,965%
March, 2026 $144.90 $160.70 $170.15 +6,486%
April, 2026 $124.88 $127.08 $124.81 +5,576%
May, 2026 $85.74 $109.14 $121.51 +3,797%
June, 2026 $129.81 $129.29 $123.41 +5,800%
July, 2026 $159.29 $139.84 $150.49 +7,140%
August, 2026 $152.25 $156.85 $155.54 +6,821%
September, 2026 $157.83 $154.69 $154.63 +7,074%
October, 2026 $169.70 $167.95 $166.70 +7,614%
November, 2026 $165.76 $169.76 $173.93 +7,435%
December, 2026 $176.74 $167.68 $173.43 +7,934%

Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Aytu Biopharma Inc (AYTU) is $165.18, with a high forecast of $181.69 and a low forecast of $148.67. This indicates an +7,408% increase from the last price of $2.20.
Month Average Low High Change from today's price
January, 2027 $179.21 $175.86 $175.01 +8,046%
February, 2027 $182.07 $175.44 $174.93 +8,176%
March, 2027 $183.06 $182.11 $179.46 +8,221%
April, 2027 $182.12 $182.92 $181.69 +8,178%
May, 2027 $177.59 $178.99 $180.92 +7,972%
June, 2027 $172.77 $172.77 $173.56 +7,753%
July, 2027 $168.23 $168.43 $170.28 +7,547%
August, 2027 $171.08 $167.15 $165.95 +7,676%
September, 2027 $165.04 $165.68 $168.64 +7,402%
October, 2027 $160.54 $161.32 $163.39 +7,197%
November, 2027 $150.85 $152.19 $157.61 +6,757%
December, 2027 $151.40 $148.67 $149.12 +6,782%

Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2028

In 2028, Aytu Biopharma Inc (AYTU) is projected to reach an average price of $114.28, with a high projection of $149.90 and a low estimate of $78.65. This indicates an +5,094% rise from the last price of $2.20.
Month Average Low High Change from today's price
January, 2028 $146.67 $146.87 $149.90 +6,567%
February, 2028 $141.62 $141.72 $145.18 +6,337%
March, 2028 $134.62 $134.70 $139.48 +6,019%
April, 2028 $128.17 $128.39 $132.97 +5,726%
May, 2028 $120.74 $120.74 $126.08 +5,388%
June, 2028 $115.07 $115.20 $119.11 +5,130%
July, 2028 $109.45 $109.48 $113.48 +4,875%
August, 2028 $102.92 $103.01 $107.94 +4,578%
September, 2028 $97.11 $97.18 $101.19 +4,314%
October, 2028 $91.86 $91.99 $95.22 +4,075%
November, 2028 $84.15 $84.32 $89.66 +3,725%
December, 2028 $78.43 $78.65 $82.65 +3,465%

Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2029

The 2029 price forecast for Aytu Biopharma Inc Stock (AYTU) is $199.86 on average, with a high prediction of $398.21 and a low estimate of $1.5079. This represents an +8,985% increase from the previous price of $2.20.
Month Average Low High Change from today's price
January, 2029 $70.80 $70.93 $76.77 +3,118%
February, 2029 $64.94 $65.03 $69.28 +2,852%
March, 2029 $59.12 $59.22 $63.42 +2,587%
April, 2029 $51.82 $52.21 $57.58 +2,255%
May, 2029 $44.48 $44.58 $49.82 +1,922%
June, 2029 $39.11 $39.19 $42.85 +1,678%
July, 2029 $32.68 $32.82 $37.45 +1,385%
August, 2029 $25.37 $25.37 $31.10 +1,053%
September, 2029 $19.23 $19.35 $23.91 +774.24%
October, 2029 $11.70 $11.92 $17.68 +432.02%
November, 2029 $6.0193 $6.1593 $10.09 +173.60%
December, 2029 $436.21 $1.5079 $398.21 +19,728%

Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2030

Aytu Biopharma Inc Stock (AYTU) is expected to reach an average price of $518.13 in 2030, with a high forecast of $616.42 and a low forecast of $419.84. This signifies an +23,451% surge from the last price of $2.20.
Month Average Low High Change from today's price
January, 2030 $516.38 $517.25 $506.34 +23,372%
February, 2030 $495.51 $492.47 $470.41 +22,423%
March, 2030 $561.64 $522.54 $509.24 +25,429%
April, 2030 $548.81 $566.73 $546.67 +24,846%
May, 2030 $570.93 $548.86 $556.95 +25,851%
June, 2030 $577.06 $578.02 $551.96 +26,130%
July, 2030 $642.22 $593.12 $616.42 +29,092%
August, 2030 $603.31 $624.35 $611.25 +27,323%
September, 2030 $603.46 $582.41 $559.70 +27,330%
October, 2030 $589.46 $607.51 $593.65 +26,694%
November, 2030 $505.77 $641.69 $604.74 +22,890%
December, 2030 $399.90 $419.84 $383.90 +18,077%
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
Cap:     |  Volume (24h):